ziprasidone: Clinical Trials

5 trials of ziprasidone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow ziprasidone: new trials by email Literature Review of ziprasidone trials Research Report on ziprasidone

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
Risperidone, Aripiprazole, Ziprasidone - Schizophrenia
Phase 4UnknownShanghai Mental Health Center3502021-05-012020-08-26
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
Ziprasidone - Schizophrenia
Phase 4UnknownYang Fude10002016-10-012016-10-18
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
Aripiprazole Once-Monthly, Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc) - Schizophrenia
Phase 4UnknownMatt Byerly2002014-12-012015-06-08
Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
Lithium, Valproate, Oxcarbazepine - Bipolar Disorder
Phase 4UnknownGuiyun Xu1202013-09-012015-03-17
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
Antipsychotics - Schizophrenia or Schizoaffective Disorder
Phase 4UnknownUniversity of Sao Paulo1262009-04-012009-11-19

Conditions studied

Schizophrenia (4)  ·  Bipolar Disorder (1)  ·  Medication Adherence (1)  ·  Patient Dropouts (1)  ·  Psychomotor Agitation (1)  ·  Psychotic Disorders (1)

Sponsors

Guiyun Xu (1)  ·  Matt Byerly (1)  ·  Shanghai Mental Health Center (1)  ·  University of Sao Paulo (1)  ·  Yang Fude (1)

Countries

China (3)  ·  Brazil (1)  ·  United States (1)

Top investigators

Guinyun Xu, M.D (1)  ·  Kangguang Lin, M.D (1)  ·  Matt Byerly, MD (1)  ·  Yang Fude, director (1)

Results publications

PMID 16247923, PMID 23295604, PMID 23422376